Billets de Michelle Dawson

Billet publié sur Bluesky le 22/11/2023 18:29

Bluesky Publication avec DOI crossref Extrait cité dans le billet Question posée par Dawson dans le billet Lien intégré au billet Termes sur l’autisme

Liens cités structurés

1 ressource citée

Publication avec DOI Récupéré Publication crossref

Ari Ne'eman, Kenneth A. Richman, Allison M. McCarthy, Daniel Wilkenfeld (2023). A Passing Problem: Evaluating Harm and Benefit in Autism Research. Ethics & Human Research, 45(6), 2-18. Wiley.

Date de publication
21/11/2023
Identifiant
10.1002/eahr.500188
Auteurs
Ari Ne'eman, Kenneth A. Richman, Allison M. McCarthy, Daniel Wilkenfeld
Source
Ethics & Human Research
Détails
45(6), 2-18
Type de référence
article
Éditeur
Wiley
Source de métadonnées
crossref

Résumé

ABSTRACT Autism research frequently seeks to evaluate interventions or inform their development. Unfortunately, researchers often assume that autism intervention should reduce autistic traits, effectively setting as a goal of treatment that autistic people attempt to “pass” as nonautistic. A growing body of evidence highlights serious potential harms from passing demands. We discuss why it is important for institutional review boards (IRBs) to scrutinize autism research for clinical passing demands, and we document the existence of such demands in outcome measures commonly employed in autism research. We propose an ethical framework for IRBs and others to make use of in evaluating the ethical appropriateness of particular treatment goals in autism intervention or intervention‐adjacent research, emphasizing that treatment goals should be in pursuit of a beneficial nonpassing purpose and be the least burdensome means of accomplishing such a purpose. We also highlight potential promising practices for IRBs, investigators, and other stakeholders seeking to address these issues in autism research.

Auteur·ices de l’étude dans cette référence citée